Companies: 10,795·Total market cap: $144.5T
Q BioMed Inc.

Q BioMed Inc.

QBIOOTCHealthcare
$0.00
$-0.00(-0.00%)
Market Cap$14509
P/E Ratio—
52W High$0.02505
52W Low$0.000099999997
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Q BioMed Inc. (QBIO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · QBIO · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.03qbio eps ttm · qbio earnings per shareEarnings history
PE Ratio (TTM)—qbio pe ratio ttm · qbio price to earningsPE Ratio deep dive
Revenue (TTM)211793.00qbio revenue ttm · qbio annual revenueFull revenue history
Dividend YieldNo Dividenddoes qbio pay dividends · qbio dividend yieldDividend history
Shares Outstanding44.8Mqbio shares outstanding · qbio floatShares outstanding history
Next EarningsTBAqbio earnings date · qbio next earningsEarnings history

Explore Q BioMed Inc. Data

qbio stock data · financials
Market Cap$14,509qbio market cap · qbio valuation
Analyst Forecast$— · Hold
DividendsNo Dividenddoes q biomed inc. pay dividends · qbio dividend yield
Revenue$284352+45.38%q biomed inc. annual revenue · qbio revenue
EarningsEPS $-0.08+76.33%qbio earnings · qbio eps
PE Ratio—qbio pe ratio · qbio price to earnings

Financial Snapshot

Full Financials
FY 2022Revenue$284352.00▲ +45.38% YoY
202020212022
q biomed inc. revenue · qbio revenue 2022
FY 2022Net Income-$2.1M▲ +75.10% YoY
202020212022
q biomed inc. net income · qbio profit 2022
FY 2022EPS$-0.08▲ +76.33% YoY
202020212022
qbio eps · q biomed inc. earnings per share 2022
TTM:Revenue: $211793.00Net Income: -$1.2MEPS: $-0.03View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold1 analystsis qbio a buy · qbio analyst rating
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$0.00Current
$—Avg Target
$—High
qbio price target · qbio 12 month forecast

Total: 1 · Buy rate: 0.0%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD-0.00%
1Y-0.00%
5Y-99.99%

About Q BioMed Inc.

CEODenis D. Corin
IPO DateJun 17, 2015
Employees3
CountryUS
Websiteqbiomed.com

Q BioMed Inc. functions as a biomedical accelerator and developer, actively licensing, acquiring, and supplying resources to firms within the life sciences and healthcare sectors. Its commercial portf…

BiotechnologyHealthcareOTCUS

what is q biomed inc. · qbio stock overview · q biomed inc. company profile · who is q biomed inc. ceo · qbio OTC · q biomed inc. headquarters · q biomed inc. business segments

About Stock Overview & Key Data

Q BioMed Inc. (QBIO) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 17, 2015. As of the latest trading session, QBIO stock price is $0.00, with a market capitalization of $14,509. The stock has returned -0.00% over the past 12 months and -0.00% year-to-date.

According to 1 Wall Street analysts, the consensus rating for Q BioMed Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2022, Q BioMed Inc. reported revenue of $284352.00 and net income of -$2.1M. For detailed data — including Q BioMed Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Q BioMed Inc. (QBIO) stock price is $0.00. The stock is traded on OTC under the ticker symbol QBIO. The 52-week range is $0.00 – $0.03.

QBIO stock priceQBIO quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice